ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 112 filers reported holding ENDOLOGIX INC in Q2 2017. The put-call ratio across all filers is 63.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $120,000 | +46.3% | 21,139 | +9.5% | 0.00% | 0.0% |
Q1 2018 | $82,000 | -23.4% | 19,300 | -3.5% | 0.00% | 0.0% |
Q4 2017 | $107,000 | -35.9% | 20,000 | -46.7% | 0.00% | -50.0% |
Q3 2017 | $167,000 | -31.3% | 37,500 | -25.0% | 0.01% | -40.0% |
Q2 2017 | $243,000 | -32.9% | 50,000 | 0.0% | 0.01% | -28.6% |
Q1 2017 | $362,000 | +50.8% | 50,000 | +19.0% | 0.01% | +16.7% |
Q4 2016 | $240,000 | -89.2% | 42,000 | -67.7% | 0.01% | -87.9% |
Q1 2015 | $2,219,000 | -3.3% | 130,000 | -13.3% | 0.10% | +25.3% |
Q4 2014 | $2,294,000 | +44.3% | 150,000 | 0.0% | 0.08% | +102.6% |
Q3 2014 | $1,590,000 | -30.3% | 150,000 | 0.0% | 0.04% | -22.0% |
Q2 2014 | $2,282,000 | -15.6% | 150,000 | -28.6% | 0.05% | -7.4% |
Q1 2014 | $2,703,000 | +4.3% | 210,000 | +41.3% | 0.05% | -3.6% |
Q4 2013 | $2,592,000 | -55.4% | 148,600 | -58.7% | 0.06% | -11.1% |
Q3 2013 | $5,810,000 | +143.1% | 360,000 | +100.0% | 0.06% | -10.0% |
Q2 2013 | $2,390,000 | – | 180,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Capital Management, LLC | 4,050,000 | $49,653,000 | 5.91% |
Essex Woodlands Management, Inc. | 1,257,468 | $21,220,000 | 3.88% |
PURA VIDA INVESTMENTS, LLC | 205,100 | $2,515,000 | 1.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,347,113 | $28,776,000 | 1.11% |
First Light Asset Management, LLC | 180,963 | $2,219,000 | 1.10% |
ArrowMark Colorado Holdings LLC | 2,889,546 | $35,426,000 | 0.97% |
PALISADE CAPITAL MANAGEMENT, LP | 2,149,949 | $26,358,000 | 0.78% |
Iguana Healthcare Management, LLC | 150,000 | $1,839,000 | 0.72% |
CADIAN CAPITAL MANAGEMENT, LP | 1,492,443 | $18,297,000 | 0.66% |
WASHINGTON CAPITAL MANAGEMENT, INC | 85,882 | $1,053,000 | 0.66% |